Compare CWH & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CWH | CRVS |
|---|---|---|
| Founded | 1966 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Auto Dealers and Gas Stations | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 2016 | 2016 |
| Metric | CWH | CRVS |
|---|---|---|
| Price | $6.58 | $14.41 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 5 |
| Target Price | $15.89 | ★ $28.20 |
| AVG Volume (30 Days) | ★ 3.2M | 1.1M |
| Earning Date | 04-28-2026 | 03-12-2026 |
| Dividend Yield | ★ 7.32% | N/A |
| EPS Growth | N/A | ★ 48.04 |
| EPS | ★ 3.99 | N/A |
| Revenue | ★ $4,792,017,000.00 | N/A |
| Revenue This Year | $4.63 | N/A |
| Revenue Next Year | $5.85 | N/A |
| P/E Ratio | $1.71 | ★ N/A |
| Revenue Growth | ★ 11.83 | N/A |
| 52 Week Low | $5.70 | $2.54 |
| 52 Week High | $19.64 | $26.95 |
| Indicator | CWH | CRVS |
|---|---|---|
| Relative Strength Index (RSI) | 36.82 | 44.97 |
| Support Level | $5.70 | $12.95 |
| Resistance Level | $18.18 | $18.73 |
| Average True Range (ATR) | 0.43 | 1.01 |
| MACD | 0.23 | 0.03 |
| Stochastic Oscillator | 71.43 | 42.98 |
Camping World Holdings Inc is a retailer of RVs and related products and services. The company has two reportable segments; the Good Sam Services and Plans segment, which includes the sale of emergency roadside assistance plans; commissions on property and casualty insurance programs; travel assist programs; extended vehicle service contracts; vehicle financing and refinancing assistance; consumer shows and events; and consumer publications and directories; and the RV and Outdoor Retail segment, which generates maximum revenue and includes the sale of new and used RVs; commissions on the finance and insurance contracts related to the sale of RVs; the sale of RV service and collision work; the sale of RV parts, accessories, business to business distribution of RV furniture, etc.
Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.